JF
CABA icon

Jump Financial’s Cabaletta Bio CABA Stock Holding History

Jump Financial’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
488,775
+472,075
+2,827% +$1.55M 0.01% 1002
2026
Q1 		$44.9K Buy
+16,700
New +$46.4K ﹤0.01% 1792
2024
Q4 		– Sell
-109,786
Closed -$518K – 1673
2024
Q3 		$518K Sell
109,786
-72,349
-40% -$419K 0.01% 1089
2024
Q2 		$1.36M Buy
+182,135
New +$2.23M 0.03% 696

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jump Financial's CABA Position: Q2 2026 in Review

Jump Financial increased its Cabaletta Bio (CABA) stake by 2,827% in Q2 2026, buying an estimated $1.55M and bringing the position to 488,775 shares worth $1.52M. The position accounts for 0.01% of the portfolio, ranked #1002.

Jump Financial first reported a position in CABA in Q2 2024 and has held it in 4 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Jump Financial held 488,775 shares of Cabaletta Bio worth $1.52M as of Q2 2026.
  • Jump Financial bought 472,075 Cabaletta Bio shares in Q2 2026, an estimated $1.55M.
  • Cabaletta Bio made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1002 holding.
  • Jump Financial first reported a position in Cabaletta Bio in Q2 2024 and has held it in 4 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.